Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 421, 461-462 (30 January 2003) | doi:10.1038/421461a
Open Innovation Challenges
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
- More Challenges
- Powered by:
nature jobs
Research Fellows in Pluripotent Stem Cell Technology
- The University of Nottingham
- Nottingham, UK
Laboratory Manager / Principal Research Assistant
- Wellcome Trust Sanger Institute
- Hinxton, Cambridge, CB10 1SA, UK
Gates ploughs millions into plan for assault on killer diseases
Declan Butler
Microsoft founder Bill Gates is to provide US$200 million for basic biological research into the treatment and control of killer diseases such as malaria and tuberculosis.The initiative, a partnership between the Bill & Melinda Gates Foundation in Seattle, Washington, and the US National Institutes of Health (NIH), will establish several large consortia to research diseases that kill millions of people in poor countries, but which are often neglected by biomedical research programmes in rich countries.
To read this story in full you will need to login or make a payment (see right).
